Revenue
$5.96B
Fiscal year ended 2026-01-31Operating income
$120.43M
Fiscal year ended 2026-01-31Free cash flow
$186.95M
Fiscal year ended 2026-01-31Petco Health & Wellness Company, Inc. (WOOF) reported revenue of $5.96B and net income of $9.07M for the fiscal year ended 2026-01-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Petco Health & Wellness Company, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Retail-Retail Stores, NEC.
Income
| Metric | 2026-01-31 | 2025-02-01 | 2024-02-03 | 2023-01-28 | 2022-01-29 | 2021-01-30 | 2020-02-01 |
|---|---|---|---|---|---|---|---|
| Revenue | $5.96B | $6.12B | $6.26B | $6.04B | $5.81B | $4.92B | $4.43B |
| Cost of revenue | $3.66B | $3.79B | $3.90B | $3.61B | $3.38B | $2.81B | $2.53B |
| Gross profit | $2.31B | $2.32B | $2.35B | $2.43B | $2.43B | $2.11B | $1.91B |
| Operating income | $120.43M | $7.05M | -$1.18B | $225.56M | $266.07M | $194.42M | $110.60M |
| Net income | $9.07M | -$101.82M | -$1.28B | $90.80M | $164.42M | -$26.48M | -$95.87M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 286.15M | shares 273.41M | shares 267.55M | shares 265.95M | Unavailable | Unavailable | Unavailable |
| Pretax income | $15.33M | -$109.30M | -$1.31B | $112.28M | $202.40M | -$41.56M | -$142.08M |
| Income tax expense | $6.27M | -$7.48M | -$27.61M | $35.35M | $53.47M | -$3.34M | -$35.66M |
| Diluted EPS | $0.03 | $-0.37 | $-4.78 | $0.34 | $0.62 | $-0.13 | $-0.46 |
| Selling, general & administrative | $2.18B | $2.32B | $2.31B | $2.20B | $2.16B | $1.91B | $1.78B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-01-31 | 2025-02-01 | 2024-02-03 | 2023-01-28 | 2022-01-29 | 2021-01-30 | 2020-02-01 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $256.74M | $165.76M | $125.43M | $201.90M | $211.60M | $111.40M | Unavailable |
| Total assets | $5.17B | $5.19B | $5.36B | $6.61B | $6.50B | $6.08B | Unavailable |
| Current assets | $1.02B | $973.62M | $951.74M | $1.02B | $1.07B | $777.55M | Unavailable |
| Total liabilities | $4.01B | $4.08B | $4.18B | $4.23B | $4.24B | $4.02B | Unavailable |
| Current liabilities | $1.13B | $1.14B | $1.11B | $1.02B | $1.05B | $875.31M | Unavailable |
| Total equity incl. NCI | $1.16B | $1.11B | $1.18B | $2.38B | $2.26B | $2.06B | $561.06M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $590.21M | $653.33M | $684.50M | $652.43M | $675.11M | $538.68M | Unavailable |
| Accounts receivable | $45.81M | $40.42M | $44.37M | $49.58M | $55.62M | $41.83M | Unavailable |
| Goodwill | $980.06M | $980.06M | $980.30M | $2.19B | $2.18B | $2.18B | $2.18B |
| Long-term debt | $1.49B | $1.58B | $1.58B | $1.63B | $1.64B | $1.65B | Unavailable |
| Accounts payable | $450.55M | $492.88M | $485.13M | $381.21M | $403.98M | $339.48M | Unavailable |
Cash flow
| Metric | 2026-01-31 | 2025-02-01 | 2024-02-03 | 2023-01-28 | 2022-01-29 | 2021-01-30 | 2020-02-01 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $314.05M | $177.67M | $215.72M | $346.00M | $358.22M | $268.62M | $110.34M |
| Capital expenditures | $127.10M | $127.99M | $225.60M | $278.02M | $239.11M | $159.56M | $156.91M |
| Investing cash flow | -$124.56M | -$123.90M | -$207.44M | -$320.32M | -$237.08M | -$157.18M | -$139.04M |
| Financing cash flow | -$101.75M | -$8.75M | -$85.35M | -$33.84M | -$18.78M | -$146.61M | -$3.07M |
| Net change in cash | $87.75M | $45.02M | -$77.08M | -$8.16M | $102.35M | -$35.18M | -$31.78M |
| Stock-based compensation | $32.65M | $50.21M | $81.86M | $60.78M | $49.26M | $12.92M | $9.49M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $196.71M | $208.52M | $203.62M | $193.83M | $172.43M | $174.84M | $173.54M |
Derived
| Metric | 2026-01-31 | 2025-02-01 | 2024-02-03 | 2023-01-28 | 2022-01-29 | 2021-01-30 | 2020-02-01 |
|---|---|---|---|---|---|---|---|
| Free cash flow | $186.95M | $49.68M | -$9.88M | $67.98M | $119.10M | $109.06M | -$46.57M |
| Gross margin | 38.7% | 38.0% | 37.6% | 40.2% | 41.8% | 42.8% | 43.0% |
| Operating margin | 2.0% | 0.1% | -18.9% | 3.7% | 4.6% | 4.0% | 2.5% |
| FCF margin | 3.1% | 0.8% | -0.2% | 1.1% | 2.1% | 2.2% | -1.1% |
| SBC / revenue | 0.5% | 0.8% | 1.3% | 1.0% | 0.8% | 0.3% | 0.2% |
| Current ratio | 0.90x | 0.85x | 0.86x | 0.99x | 1.02x | 0.89x | Unavailable |
| Revenue YoY growth | -2.5% | -2.2% | 3.6% | 3.9% | 18.0% | 11.0% | Unavailable |
| Net margin | 0.2% | -1.7% | -20.5% | 1.5% | 2.8% | -0.5% | -2.2% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 2.1% | 2.1% | 3.6% | 4.6% | 4.1% | 3.2% | 3.5% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 40.9% | Unavailable | Unavailable | 31.5% | 26.4% | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open WOOF in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-09-04View SEC filing
10-Q · Filed 2026-06-05View SEC filing
10-K · Filed 2026-03-13View SEC filing
10-Q · Filed 2025-12-05View SEC filing
10-Q · Filed 2025-08-29View SEC filing
10-Q · Filed 2025-06-06View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.